Eagle Pharmaceuticals (EGRX) Fails to deliver data

Key failure to deliver metrics for Eagle Pharmaceuticals :

• Last SEC data release: 2024-06-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: S$0 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eagle Pharmaceuticals (EGRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eagle Pharmaceuticals (EGRX) - since 2014

Eagle Pharmaceuticals (EGRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	S$0.18 B	S$0.40 B	🇺🇸 USA
Novartis NVS	S$32.89 M	S$0.43 B	🇨🇭 Switzerland
Eli Lilly LLY	S$40.93 M	S$0.36 B	🇺🇸 USA
Amgen AMGN	S$25.92 M	S$0.45 B	🇺🇸 USA
Bristol-Myers Squibb BMY	S$17.12 M	S$92.07 M	🇺🇸 USA
GSK plc GSK	S$54.15 M	S$0.19 B	🇬🇧 UK
Teva Pharmaceutical Industries TEVA	S$7.36 M	S$74.34 M	🇮🇱 Israel